Edison resident named medical director of Atlantic Health System’s Heart Success program


Atlantic Health System announced that Abhishek Singh, MD, PhD, has been named medical director of Atlantic Health System’s Heart Success program, which cares for patients with advanced heart failure.

Singh, a longtime Edison resident, is triple board-certified in internal medicine, cardiology, and advanced heart failure and transplant cardiology.

“As one of the nation’s leading cardiology and cardiothoracic surgery programs, we take great pride in being able to offer our patients the most advanced, subspecialized evidence-based care,” Linda D. Gillam, MD, MPH, MACC, Dorothy and Lloyd Huck Chair, Department of Cardiovascular Medicine and medical director, Cardiovascular Service Line, Morristown Medical Center/Atlantic Health System, said in a prepared statement. “We are very happy that Dr. Singh brings his unique expertise to further strengthen our existing multidisciplinary heart failure program and best serve our patients.”

Singh joins Atlantic Health System from St. Luke’s University Hospital in Bethlehem, Pennsylvania, and Temple University Hospital in Philadelphia, where he served as an attending physician in the hospitals’ advanced heart failure and pulmonary hypertension programs starting in 2016, according to the statement.

During that time, he also served as an adjunct assistant professor in the Lewis Katz School of Medicine at Temple University.

“I am honored to join the exemplary cardiovascular medicine team at Atlantic Health System and thrilled to be based at the top-ranked Morristown Medical Center,” Singh said in the statement. “I am especially excited to work with the advanced practice nurses (APNs), and the rest of the exceptional Heart Success team.”

Singh uses evidence-based medicine to co-manage advanced and complicated heart failure and pulmonary hypertension patients, according to the statement. In collaboration with a multidisciplinary team that includes physicians, APNs, and nurses, he cares for patients with hard-to-control heart conditions by using electrophysiologic and hemodynamic support devices. He utilizes exercise right heart catheterization to help determine the various contributors to patients’ shortness of breath (dyspnea). In addition, he evaluates and manages pre- and post-heart transplant patients.

After receiving his medical degree from Rutgers-Robert Wood Johnson Medical School, Singh pursued his internship and residency at the University of California, San Francisco (UCSF). He remained there for his cardiology fellowship in the UCSF Molecular Medicine Program (Physician Scientist Training Program). He returned to the east coast to pursue a second fellowship in Advanced Heart Failure and Transplant Cardiology at Temple University Hospital. Prior to his medical training, Singh received his bachelor’s degrees in biology and chemistry from the Massachusetts Institute of Technology (MIT).

Singh has published extensively in peer reviewed journals and has presented at numerous major international medical scientific meetings, according to the statement. He has served as principal investigator (PI) or co-PI on a number of research studies funded by the National Institutes of Health. He is the recipient of numerous awards and honors, including Most Outstanding MD/PhD Student from Rutgers-Robert Wood Johnson Medical School.

Singh is a member of the International Society of Heart and Lung Transplantation and the Heart Failure Society of America.